August 24, 2023 By Jim Hammerand After Medtronic’s latest setback, what’s next for Symplicity Spyral RDN?
August 23, 2023 By Jim Hammerand Risks of Medtronic Symplicity Spyral renal denervation (RDN) outweigh benefits: FDA review panel
November 12, 2021 By Jim Hammerand CMS puts final nail in MCIT payment proposal for breakthrough devices